Kristin Yarema - Chief Commercial Officer at Atara Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
ATRA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kristin Yarema since 11/23/2023

Holdings reported by Kristin Yarema for Atara Biotherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 171K $66.7K $0.39 Mar 1, 2022 Direct
Employee Stock Option (Right to Buy) 85.6K Mar 1, 2022 Direct Common Stock

Transactions reported by Kristin Yarema for Atara Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.